Annals of Surgical Oncology

, Volume 20, Issue 5, pp 1456–1461

Comparative Outcomes of Laparoscopic and Open Adrenalectomy for Adrenocortical Carcinoma: Single, High-Volume Center Experience

  • Maria C. Mir
  • Joseph C. Klink
  • Julien Guillotreau
  • Jean-Alexandre Long
  • Ranko Miocinovic
  • Jihad H. Kaouk
  • Matthew N. Simmons
  • Eric Klein
  • Venkatesh Krishnamurthi
  • Steven C. Campbell
  • Amr F. Fergany
  • Jordan Reynolds
  • Andrew J. Stephenson
  • Georges-Pascal Haber
Endocrine Tumors

Abstract

Purpose

Adrenocortical carcinoma (ACC) is a rare and clinically aggressive cancer. Previous studies reported increased recurrence rates associated with laparoscopic adrenalectomy (LA). We evaluated a single-center experience of LA versus open adrenalectomy (OA) for the management of ACC.

Methods

Between 1993 and 2011, 44 consecutive patients with primary ACC were treated at our institution. Baseline patient characteristics and surgical and pathological outcomes were compared between OA and LA groups. Multivariable Cox proportional hazards analysis was used to estimate the association between OA versus LA with recurrence-free and overall survival.

Results

Eighteen and 26 patients underwent LA and OA, respectively. Patients who underwent OA had larger tumors and more advanced clinical stage compared with LA group. During a median follow-up of 22 months, 22 recurrences and 26 deaths were observed. The 2-year, recurrence-free and overall survivals for OA and LA were 60 vs. 39 % (P = 0.7) and 54 vs. 58 % (P = 0.6), respectively. After adjusting for clinical stage, OA was associated with lower risk of recurrence (hazard ratio (HR) 0.4; 95 % confidence interval (CI) 0.2–1.2; P = 0.099) and improved overall survival (HR 0.5; 95 % CI 0.2–1.2; P = 0.122) compared with LA, although differences were not statistically significant.

Conclusions

A nonstatistically significant increase in recurrence and death was observed among patients undergoing LA versus OA after adjusting for clinical stage. The rarity of this disease limits the ability to assess for significant differences in a single-institution series. Patients with suspected ACC should be considered for OA.

References

  1. 1.
    Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012;62(1):10–29.PubMedCrossRefGoogle Scholar
  2. 2.
    Bilimoria KY, Shen WT, Elaraj D, Bentrem DJ, Winchester DJ, Kebebew E, et al. Adrenocortical carcinoma in the United States: treatment utilization and prognostic factors. Cancer. 2008;113(11):3130–6.PubMedCrossRefGoogle Scholar
  3. 3.
    Prinz RA. A comparison of laparoscopic and open adrenalectomies. Arch Surg. 1995;130(5):489–92; discussion 92–4.Google Scholar
  4. 4.
    Thompson GB, Grant CS, van Heerden JA, Schlinkert RT, Young WF, Farley DR, et al. Laparoscopic versus open posterior adrenalectomy: a case-control study of 100 patients. Surgery. 1997;122(6):1132–6.PubMedCrossRefGoogle Scholar
  5. 5.
    Lee J, El-Tamer M, Schifftner T, Turrentine FE, Henderson WG, Khuri S, et al. Open and laparoscopic adrenalectomy: analysis of the National Surgical Quality Improvement Program. J Am Coll Surg. 2008;206(5):953–9; discussion 9–61.Google Scholar
  6. 6.
    Gumbs AA, Gagner M. Laparoscopic adrenalectomy. Best Pract Res Clin Endocrinol Metab. 2006;20(3):483–99.PubMedCrossRefGoogle Scholar
  7. 7.
    Schulick RD, Brennan MF. Long-term survival after complete resection and repeat resection in patients with adrenocortical carcinoma. Ann Surg Oncol. 1999;6(8):719–26.PubMedCrossRefGoogle Scholar
  8. 8.
    Suzuki K, Ushiyama T, Ihara H, Kageyama S, Mugiya S, Fujita K. Complications of laparoscopic adrenalectomy in 75 patients treated by the same surgeon. Eur Urol. 1999;36(1):40–7.PubMedCrossRefGoogle Scholar
  9. 9.
    Deckers S, Derdelinckx L, Col V, Hamels J, Maiter D. Peritoneal carcinomatosis following laparoscopic resection of an adrenocortical tumor causing primary hyperaldosteronism. Horm Res. 1999;52(2):97–100.PubMedCrossRefGoogle Scholar
  10. 10.
    Gonzalez RJ, Shapiro S, Sarlis N, Vassilopoulou-Sellin R, Perrier ND, Evans DB, et al. Laparoscopic resection of adrenal cortical carcinoma: a cautionary note. Surgery. 2005;138(6):1078–85; discussion 85–6.Google Scholar
  11. 11.
    Miller BS, Ammori JB, Gauger PG, Broome JT, Hammer GD, Doherty GM. Laparoscopic resection is inappropriate in patients with known or suspected adrenocortical carcinoma. World J Surg. 2010;34(6):1380–5.PubMedCrossRefGoogle Scholar
  12. 12.
    Brix D, Allolio B, Fenske W, Agha A, Dralle H, Jurowich C, et al. Laparoscopic versus open adrenalectomy for adrenocortical carcinoma: surgical and oncologic outcome in 152 patients. Eur Urol. 2010;58(4):609–15.PubMedCrossRefGoogle Scholar
  13. 13.
    Gill IS, Schweizer D, Hobart MG, Sung GT, Klein EA, Novick AC. Retroperitoneal laparoscopic radical nephrectomy: the Cleveland Clinic experience. J Urol. 2000;163(6):1665–70.PubMedCrossRefGoogle Scholar
  14. 14.
    Moinzadeh A, Gill IS. Laparoscopic radical adrenalectomy for malignancy in 31 patients. J Urol. 2005;173(2):519–25.PubMedCrossRefGoogle Scholar
  15. 15.
    Guz BV, Straffon RA, Novick AC. Operative approaches to the adrenal gland. Urol Clin North Am. 1989;16(3):527–34.PubMedGoogle Scholar
  16. 16.
    Morgan M, Smith N, Thomas K, Murphy DG. Is Clavien the new standard for reporting urological complications? BJU Int. 2009;104(4):434–6.PubMedCrossRefGoogle Scholar
  17. 17.
    Weiss LM. Comparative histologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors. Am J Surg Pathol. 1984;8(3):163–9.PubMedCrossRefGoogle Scholar
  18. 18.
    Aubert S, Wacrenier A, Leroy X, Devos P, Carnaille B, Proye C, et al. Weiss system revisited: a clinicopathologic and immunohistochemical study of 49 adrenocortical tumors. Am J Surg Pathol. 2002;26(12):1612–9.PubMedCrossRefGoogle Scholar
  19. 19.
    van Slooten H, Schaberg A, Smeenk D, Moolenaar AJ. Morphologic characteristics of benign and malignant adrenocortical tumors. Cancer. 1985;55(4):766–73.PubMedCrossRefGoogle Scholar
  20. 20.
    Zeiger MA, Thompson GB, Duh QY, Hamrahian AH, Angelos P, Elaraj D, et al. American Association of Clinical Endocrinologists and American Association of Endocrine Surgeons Medical Guidelines for the Management of Adrenal Incidentalomas: executive summary of recommendations. Endocr Pract. 2009;15(5):450–3.PubMedGoogle Scholar
  21. 21.
    Allolio B, Fassnacht M. Clinical review: Adrenocortical carcinoma: clinical update. J Clin Endocrinol Metab. 2006;91(6):2027–37.PubMedCrossRefGoogle Scholar
  22. 22.
    Porpiglia F, Fiori C, Daffara F, Zaggia B, Bollito E, Volante M, et al. Retrospective evaluation of the outcome of open versus laparoscopic adrenalectomy for stage I and II adrenocortical cancer. Eur Urol. 2010;57(5):873–8.PubMedCrossRefGoogle Scholar
  23. 23.
    Guerrieri M, De Sanctis A, Crosta F, Arnaldi G, Boscaro M, Lezoche G, et al. Adrenal incidentaloma: surgical update. J Endocrinol Invest. 2007;30(3):200–4.PubMedGoogle Scholar
  24. 24.
    Reibetanz J, Jurowich C, Erdogan I, Nies C, Rayes N, Dralle H, et al. Impact of lymphadenectomy on the oncologic outcome of patients with adrenocortical carcinoma. Ann Surg. 2012;255(2):363–9.PubMedCrossRefGoogle Scholar

Copyright information

© Society of Surgical Oncology 2012

Authors and Affiliations

  • Maria C. Mir
    • 1
  • Joseph C. Klink
    • 1
  • Julien Guillotreau
    • 1
  • Jean-Alexandre Long
    • 1
  • Ranko Miocinovic
    • 1
  • Jihad H. Kaouk
    • 1
  • Matthew N. Simmons
    • 1
  • Eric Klein
    • 1
  • Venkatesh Krishnamurthi
    • 1
  • Steven C. Campbell
    • 1
  • Amr F. Fergany
    • 1
  • Jordan Reynolds
    • 2
  • Andrew J. Stephenson
    • 1
  • Georges-Pascal Haber
    • 1
  1. 1.Glickman Urological and Kidney Institute, Cleveland ClinicClevelandUSA
  2. 2.Pathology Molecular Institute, Cleveland ClinicClevelandUSA

Personalised recommendations